China Pharmaceutical Distribution Industry Report, 2017-2021

  • ID: 4396078
  • Report
  • Region: China
  • 100 Pages
  • Research In China
1 of 5
The Industry Rose by 10.4% Year on Year to RMB1.8393 Trillion in 2016 and is Expected to Hit RMB2.9784 Trillion in 2021

FEATURED COMPANIES

  • China Meheco Co., Ltd.
  • Luyan Pharma Co., Ltd.
  • MORE

The Chinese pharmaceutical distribution market has developed steadily but at a slower rate in recent years. The industry rose by 10.4% year on year to RMB1.8393 trillion in 2016 and is expected to hit RMB2.9784 trillion in 2021 at a growth rate of 10% over the next five years driven by favorable policies and downstream demand.

Western medicine sales dominate the Chinese pharmaceutical distribution market, accounting for 74.4% in 2016; East China and Central South China hold relatively higher percentages, up to 61.1% together in 2016.

The country has developed a competitive landscape where there are national pharmaceutical distributors represented by China National Pharmaceutical Group Corporation (Sinopharm), China Resources Pharmaceutical Commercial Group, Shanghai Pharmaceuticals and Jointown Pharmaceutical Group and regional ones represented by NanJing Pharmaceutical, Guangzhou Pharmaceuticals, Chongqing Pharmaceutical, Huadong Medicine, Sichuan Kelun, Zhejiang Int'l, Realcan Pharmaceutical, Guangxi Liuzhou Pharmaceutical Co., Ltd. and Luyan Pharma Co., Ltd. which compete with each other.

By the end of Nov 2016, there were 12,975 pharmaceutical wholesalers nationwide which competed fiercely in a lowly concentrated market. Top3 champions seized only a combined 28.7% share of the market in 2016.

As medical reform policies are implemented and consolidation in pharmaceutical wholesale industry accelerates, the Chinese pharmaceutical distribution market will show trends as follows: 1) pharmaceutical E-commerce will become an important model; 2) pharmaceutical supply chain management will be upgraded; 3) capital market will play a bigger role in integration of enterprises; 4) cross-border integration of pharmaceuticals and E-commerce will continue; 5) stiffer competition will improve market concentration; 6) Wholesale-retail integration will spur industry consolidation.

China Pharmaceutical Distribution Industry Report, 2017-2021 highlights the following:

  • Pharmaceutical distribution industry in China (development environment, status quo, market size/structure, competitive landscape, development trends, etc.);
  • Chinese pharmaceutical retail market (market size, quantity, top100 pharmacy chains, online pharmacy, independent pharmacy, etc.);
  • 15 Chinese pharmaceutical distributors (profile, operation, revenue structure, gross margin, development prospects, etc.)

*The Chinese Version of this Report is Available on Request.

READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • China Meheco Co., Ltd.
  • Luyan Pharma Co., Ltd.
  • MORE

1. Overview of Pharmaceutical Distribution Industry
1.1 Definition
1.2 Industry Chain
1.3 Strength and Weakness of Pharmaceutical Chain Enterprises
1.3.1 Strength of Pharmaceutical Chain Enterprises
1.3.2 Weakness of Pharmaceutical Chain Enterprises

2 Pharmaceutical Distribution Industry in China
2.1 Development Environment
2.1.1 Policy
2.1.2 Economy
2.1.3 Medical Institution
2.1.4 Health Expenditure
2.1.5 Aging
2.1.6 Per Capita Disposable Income
2.2 Status Quo
2.3 Market Size
2.4 Market Structure
2.5 Competitive Landscape
2.6 Development Trends
2.6.1 Pharmaceutical E-commerce Becomes an Important Model
2.6.2 Operating Efficiency and Service Functions Gets Improved Constantly
2.6.3 Capital Market Plays a Bigger Role in Integration of Enterprises
2.6.4 Pharmaceutical Supply-chain Management Services Are Upgraded Rapidly
2.6.5 Cross-border Integration of Pharmaceuticals and E-commerce Continues
2.6.6 Stiffer Competition Improves Market Concentration
2.6.7 Growing Trend towards Regionalization
2.6.8 Wholesale-retail Integration Spurs Industry Consolidation

3 Chinese Drug Retail Market
3.1 Market Size
3.2 Quantity
3.3 Top100 Pharmacy Chains
3.3.1 Revenue
3.3.2 Branch
3.4 Online Pharmacy
3.5 Independent Pharmacy

4 Major Enterprises
4.1 China National Accord Medicines Corporation Ltd.
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Major Customers
4.1.5 Pharmaceutical Distribution Business
4.1.6 Development Forecast
4.2 Nanjing Pharmaceutical Co., Ltd.
4.2.1 Profile
4.2.2 Operation
4.2.3 Revenue Structure
4.2.4 Gross Margin
4.2.5 Development Forecast
4.3 Shanghai No.1 Pharmacy Co., Ltd.
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 Development Forecast
4.4 China National Medicines Corporation Ltd.
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Gross Margin
4.4.5 Development Forecast
4.5 Huadong Medicine Co., Ltd.
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Gross Margin
4.5.5 Major Customers
4.5.6 Development Forecast
4.6 Cachet Pharmaceutical Co., Ltd.
4.6.1 Profile
4.6.2 Operation
4.6.3 Revenue Structure
4.6.4 Gross Margin
4.6.5 Major Customers
4.6.6 Development Forecast
4.7 Jointown Pharmaceutical Group Co., Ltd.
4.7.1 Profile
4.7.2 Operation
4.7.3 Revenue Structure
4.7.4 Gross Margin
4.7.5 Major Customers
4.7.6 Development Forecast
4.8 Realcan Pharmaceutical Co., Ltd.
4.8.1 Profile
4.8.2 Operation
4.8.3 Revenue Structure
4.8.4 Gross Margin
4.8.5 Development Forecast
4.9 Shanghai Pharmaceuticals Holding Co., Ltd.
4.9.1 Profile
4.9.2 Operation
4.9.3 Revenue Structure
4.9.4 Gross Margin
4.9.5 Development Forecast
4.10 Zhejiang Int'l Group Co., Ltd.
4.10.1 Profile
4.10.2 Operation
4.10.3 Revenue Structure
4.10.4 Gross Margin
4.10.5 Development Forecast
4.11 Zhejiang Zhenyuan Share Co., Ltd.
4.11.1 Profile
4.11.2 Operation
4.11.3 Revenue Structure
4.11.4 Gross Margin
4.11.5 Development Forecast
4.12 China Meheco Co., Ltd.
4.12.1 Profile
4.12.2 Operation
4.12.3 Revenue Structure
4.12.4 Gross Margin
4.12.5 Development Forecast
4.13 Charmacy Pharmaceutical Co., Ltd.
4.13.1 Profile
4.13.2 Operation
4.13.3 Revenue Structure
4.13.4 Gross Margin
4.13.5 Development Forecast
4.14 Luyan Pharma Co., Ltd.
4.14.1 Profile
4.14.2 Operation
4.14.3 Revenue Structure
4.14.4 Gross Margin
4.14.5 Development Forecast
4.15 China Resources Pharmaceutical Group Limited
4.15.1 Profile
4.15.2 Operation
4.15.3 Revenue Structure
4.15.4 Gross Margin
4.15.5 Development Forecast

List of Charts

  • China Pharmaceutical Distribution Channel
  • Difference between Pure Marketing and Allocation in China’s Pharmaceutical Distribution
  • China’s Laws and Regulations on Pharmaceutical Distribution Industry, 2001-2017
  • China’s GDP, 2012-2017
  • Number of Medical and Healthcare Institutions in China, 2015-2017
  • Number of Hospitals in China, 2009-2017
  • Number of Hospitals in China by Economic Type, 2009-2017
  • Health Expenditure in China, 2010-2016
  • Health Expenditure in China, 2016-2021E
  • Population Aged over 60 in China, 2009-2021E
  • Residents’ Per-capita Disposable Income and YoY Growth in China, 2011-2016
  • Business Models of China Pharmaceutical Distribution Industry by Market
  • M&A Cases in China Pharmaceutical Distribution Industry, 2016-2017
  • Pharmaceutical Distribution Market Size and YoY Growth in China, 2006-2016
  • Pharmaceutical Distribution Market Size and YoY Growth in China, 2016-2021E
  • Pharmaceutical Distribution Sales Structure in China by Type, 2016
  • Pharmaceutical Distribution Sales Structure in China by Region, 2016
  • Pharmaceutical Distribution Revenue in China by Region, 2016
  • TOP20 Pharmaceutical Distribution Enterprises in China by Operating Revenue, 2016
  • Representative Pharmaceutical Distribution Enterprises in China by Regional Market
  • Drug Retail Market Size and YoY Growth in China, 2012-2016
  • Drug Retail Market Size and YoY Growth in China, 2016-2021E
  • Number of Drug Retail Chains in China, 2012-2016
  • Drug Retail Chains in China by Number of Stores, 2012-2016
  • Number of Independent Retail Drugstores in China, 2012-2016
  • TOP100 Pharmacy Chains in China by Total Revenue, 2016
  • TOP100 Pharmacy Chains in China by Number of Pharmacies, 2016
  • TOP20 Online Pharmacies in China by Revenue, 2016
  • TOP30 Independent Pharmacies in China by Revenue, 2016
  • Revenue and Net Income of China National Accord Medicines, 2013-2017
  • Revenue Breakdown of China National Accord Medicines by Business, 2015-2016
  • Revenue Breakdown of China National Accord Medicines by Region, 2015-2016
  • China National Accord Medicines’ Revenue from Top 5 Clients, 2014-2016
  • Revenue and Net Income of China National Accord Medicines, 2016-2021E
  • Revenue and Net Income of Nanjing Pharmaceutical, 2013-2017
  • Revenue Breakdown of Nanjing Pharmaceutical by Business, 2015-2016
  • Revenue Breakdown of Nanjing Pharmaceutical by Region, 2014-2016
  • Revenue Structure of Nanjing Pharmaceutical by Region, 2014-2016
  • Gross Margin of Nanjing Pharmaceutical by Business, 2014-2016
  • Revenue and Net Income of Nanjing Pharmaceutical, 2016-2021E
  • Revenue and Net Income of Shanghai No.1 Pharmacy, 2013-2017
  • Revenue Breakdown of Shanghai No.1 Pharmacy by Business, 2014-2016
  • Revenue Structure of Shanghai No.1 Pharmacy by Business, 2014-2016
  • Gross Margin of Shanghai No.1 Pharmacy, 2014-2016
  • Gross Margin of Shanghai No.1 Pharmacy by Business, 2014-2016
  • Revenue and Net Income of Shanghai No.1 Pharmacy, 2016-2021E
  • Revenue and Net Income of China National Medicines, 2013-2017
  • Revenue Breakdown of China National Medicines by Business, 2014-2016
  • Revenue Structure of China National Medicines by Business, 2014-2016
  • Revenue Breakdown of China National Medicines by Region, 2014-2016
  • Revenue Structure of China National Medicines by Region, 2014-2016
  • Gross Margin of China National Medicines, 2014-2016
  • Gross Margin of China National Medicines by Business, 2014-2016
  • Revenue and Net Income of China National Medicines, 2016-2021E
  • Revenue and Net Income of Huadong Medicine, 2013-2017
  • Revenue Breakdown of Huadong Medicine by Sector, 2014-2016
  • Revenue Structure of Huadong Medicine by Sector, 2014-2016
  • Gross Margin of Huadong Medicine by Sector, 2014-2016
  • Huadong Medicine’s Revenue from Top5 Clients and % of Total Revenue, 2014-2016
  • Revenue and Net Income of Huadong Medicine, 2016-2021E
  • Revenue and Net Income of Cachet Pharmaceutical, 2013-2017
  • Revenue Breakdown of Cachet Pharmaceutical by Business, 2014-2017
  • Revenue Structure of Cachet Pharmaceutical by Business, 2014-2017
  • Revenue Breakdown of Cachet Pharmaceutical by Region, 2014-2017
  • Revenue Structure of Cachet Pharmaceutical by Region, 2014-2017
  • Gross Margin of Cachet Pharmaceutical’s Pharmaceutical Wholesale Business, 2014-2017
  • Cachet Pharmaceutical’s Revenue from Top5 Clients and % of Total Revenue, 2014-2017
  • Cachet Pharmaceutical’s Investment Projects with Raised Funds, 2016
  • Revenue and Net Income of Cachet Pharmaceutical, 2016-2021E
  • Revenue and Net Income of Jointown Pharmaceutical Group, 2013-2017
  • Revenue Breakdown of Jointown Pharmaceutical Group by Business, 2014-2016
  • Revenue Structure of Jointown Pharmaceutical Group by Business, 2014-2016
  • Gross Margin of Jointown Pharmaceutical Group by Business, 2014-2016
  • Jointown Pharmaceutical Group’s Revenue from Top5 Clients and % of Total Revenue, 2014-2016
  • Revenue and Net Income of Jointown Pharmaceutical Group, 2016-2021E
  • Revenue and Net Income of Realcan Pharmaceutical, 2013-2017
  • Revenue Breakdown of Realcan Pharmaceutical by Business, 2014-2016
  • Revenue Structure of Realcan Pharmaceutical by Business, 2014-2016
  • Gross Margin of Realcan Pharmaceutical by Business, 2014-2016
  • Revenue and Net Income of Realcan Pharmaceutical, 2016-2021E
  • Revenue and Net Income of Shanghai Pharmaceuticals Holding, 2013-2017
  • Revenue Breakdown of Shanghai Pharmaceuticals Holding by Business, 2014-2016
  • Revenue Structure of Shanghai Pharmaceuticals Holding by Business, 2014-2016
  • Revenue Breakdown of Shanghai Pharmaceuticals Holding by Region, 2014-2016
  • Revenue Structure of Shanghai Pharmaceuticals Holding by Region, 2014-2016
  • Gross Margin of Shanghai Pharmaceuticals Holding by Business, 2014-2016
  • Revenue and Net Income of Shanghai Pharmaceuticals Holding, 2016-2021E
  • Revenue and Net Income of Zhejiang Int'l Group, 2013-2017
  • Revenue Breakdown of Zhejiang Int'l Group by Business, 2014-2016
  • Gross Margin of Zhejiang Int'l Group’s Pharmaceutical Sales Business, 2014-2017
  • Revenue and Net Income of Zhejiang Int'l Group, 2016-2021E
  • Revenue and Net Income of Zhejiang Zhenyuan, 2013-2017
  • Revenue Breakdown of Zhejiang Zhenyuan by Business, 2014-2017
  • Revenue Structure of Zhejiang Zhenyuan by Business, 2014-2017
  • Gross Margin of Zhejiang Zhenyuan by Business, 2014-2017
  • Revenue and Net Income of Zhejiang Zhenyuan, 2016-2021E
  • Revenue and Net Income of China Meheco, 2013-2017
  • Revenue Breakdown of China Meheco by Business, 2014-2017
  • Revenue Structure of China Meheco by Business, 2014-2017
  • Gross Margin of China Meheco by Business, 2014-2017
  • Revenue and Net Income of China Meheco, 2016-2021E
  • Revenue and Net Income of Charmacy Pharmaceutical, 2013-2017
  • Revenue Breakdown of Charmacy Pharmaceutical by Product/Client, 2013-2017
  • Revenue Structure of Charmacy Pharmaceutical by Product/Client, 2013-2017
  • Gross Margin of Charmacy Pharmaceutical, 2013-2017
  • Charmacy Pharmaceutical’s Distribution Network in Guangdong as of June 2017
  • Revenue and Net Income of Charmacy Pharmaceutical, 2016-2021E
  • Luyan Pharma’s Investment Projects with Raised Funds by Initial Public Offerings
  • Revenue and Net Income of Luyan Pharma, 2013-2017
  • Revenue Breakdown of Luyan Pharma by Business, 2014-2017
  • Revenue Structure of Luyan Pharma by Business, 2014-2017
  • Gross Margin of Luyan Pharma’s Pharmaceutical Wholesale Business, 2014-2017
  • Revenue and Net Income of Luyan Pharma, 2016-2021E
  • Revenue and Net Income of China Resources Pharmaceutical Group, 2013-2017
  • Revenue Breakdown of China Resources Pharmaceutical Group by Business, 2013-2017
  • Revenue Structure of China Resources Pharmaceutical Group by Business, 2013-2017
  • Gross Margin of China Resources Pharmaceutical Group, 2013-2017
  • Distribution Network Layout of China Resources Pharmaceutical Group
  • Revenue and Net Income of China Resources Pharmaceutical Group, 2016-2021E
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Cachet Pharmaceutical Co., Ltd.
  • Charmacy Pharmaceutical Co., Ltd.
  • China Meheco Co., Ltd.
  • China National Accord Medicines Corporation Ltd.
  • China National Medicines Corporation Ltd.
  • China Resources Pharmaceutical Group Limited
  • Huadong Medicine Co., Ltd.
  • Jointown Pharmaceutical Group Co., Ltd.
  • Luyan Pharma Co., Ltd.
  • Nanjing Pharmaceutical Co., Ltd.
  • Realcan Pharmaceutical Co., Ltd.
  • Shanghai No.1 Pharmacy Co., Ltd.
  • Shanghai Pharmaceuticals Holding Co., Ltd.
  • Zhejiang Int'l Group Co., Ltd.
  • Zhejiang Zhenyuan Share Co., Ltd.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll